A transfection method of PS -AsODNs targeting ANGPTL4 in multicellular structures of hepatocarcinoma cell line

Cancer Gene Therapy

Volumn 22, Issue 5, 2015, Pages 285-290

  Kong, Q ^a,b   Wu, G ^b   Han, L ^c   Zhang, Z ^d   Du, J ^b   Sun, W ^c   Cao, L ^b  

^a TAISHAN MEDICAL UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; GLYCOSYLATED PROTEIN; PHOSPHOROTHIOIC ACID; PROTEIN ANGPTL4; UNCLASSIFIED DRUG; ANGIOPOIETIN; ANGPTL4 PROTEIN, HUMAN; ANTISENSE OLIGONUCLEOTIDE; OLIGONUCLEOTIDE PHOSPHOROTHIOATE;

ARTICLE; CARCINOMA CELL LINE; CELL AGGREGATION; CELL CULTURE; CELL VIABILITY; DRUG EFFICACY; GENETIC TRANSFECTION; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN TARGETING; SOLID TUMOR; BIOLOGICAL MODEL; CELL CULTURE TECHNIQUE; CELL GROWTH; GENE SILENCING; GENETICS; HUMAN; LIVER TUMOR; PATHOLOGY; PHYSIOLOGY; PROCEDURES; TUMOR CELL LINE;

ANGIOPOIETINS; CARCINOMA, HEPATOCELLULAR; CELL CULTURE TECHNIQUES; CELL GROWTH PROCESSES; CELL LINE, TUMOR; GENE KNOCKDOWN TECHNIQUES; HUMANS; LIVER NEOPLASMS; MODELS, BIOLOGICAL; OLIGONUCLEOTIDES, ANTISENSE; PHOSPHOROTHIOATE OLIGONUCLEOTIDES; TRANSFECTION;

EID: 84929262037     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/cgt.2015.22     Document Type: Article

References (27)

1. Bissell MJ, Rizki A, Mian IS. Tissue architecture: the ultimate regulator of breast epithelial function. Curr Opin Cell Biol 2003;15:753-762.
2. Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C et al. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 1997;137:231-245.
3. Abbott A. Cell culture: biology's new dimension. Nature 2003;424:870-872.
4. Bissell MJ, Radisky D. Putting tumours in context. Nat Rev Cancer 2001;1:46-54.
5. Breslin S, O'Driscoll L. Three-dimensional cell culture: the missing link in drug discovery. Drug Discov Today 2012;18:240-249.
6. Arrondeau J, Gan HK, Razak AR, Paoletti X, Le Tourneau C. Development of anticancer drugs. Discov Med 2010;10:355-362.
7. Hait WN. Anticancer drug development: the grand challenges. Nat Rev Drug Discov 2010;9:253-254.
8. Hopkins AL. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 2008;4:682-690.
9. Kola I. The state of innovation in drug development. Clin Pharmacol Therap 2008;83:227-230.
10. DiMasi JA, Grabowski HG. Economics of new oncology drug development. J Clin Oncol 2007;25:209-216.
11. Mazzoleni G, Di Lorenzo D, Steimberg N. Modelling tissues in 3D: the next future of pharmaco-toxicology and food research? Genes Nutr 2009;4:13-22.
12. Sleeman J, Steeg PS. Cancer metastasis as a therapeutic target. Eur J cancer 2010;46:1177-1180.
13. Chitcholtan K, Asselin E, Parent S, Sykes PH, Evans JJ. Differences in growth properties of endometrial cancer in three dimensional (3D) culture and 2D cell monolayer. Exp Cell Res 2013;319:75-87.
14. Zschenker O, Streichert T, Hehlgans S, Cordes N. Genome-wide gene expression analysis in cancer cells reveals 3D growth to affect ECM and processes associated with cell adhesion but not DNA repair. PLoS One 2012;7:e34279.
15. Yang X, Sarvestani SK, Moeinzadeh S, He X, Jabbari E. Three-dimensionalengineered matrix to study cancer stem cells and tumorsphere formation: effect of matrix modulus. Tissue Eng Part A 2012;19:669-684.
16. Xu Y, Li Q, Li XY, Yang QY, Xu WW, Liu GL. Short-term anti-vascular endothelial growth factor treatment elicits vasculogenic mimicry formation of tumors to accelerate metastasis. J Exp Clin Cancer Res 2012;31:16.
17. Zhang Z, Cao L, Li J, Liang X, Liu Y, Liu H et al. Acquisition of anoikis resistance reveals a synoikis-like survival style in BEL7402 hepatoma cells. Cancer Lett 2008;267:106-115.
18. Cao L, Han L, Zhang Z, Li J, Qu Z, Du J et al. Involvement of anoikis-resistance in the metastasis of hepatoma cells. Exp Cell Res 2009;315:1148-1156.
19. Loberg RD, Fridman Y, Pienta BA, Keller ET, McCauley LK, Taichman RS et al. Detection and isolation of circulating tumor cells in urologic cancers: a review. Neoplasia 2004;6:302-309.
20. Geiger TR, Peeper DS. Critical role for TrkB kinase function in anoikis suppression, tumorigenesis, and metastasis. Cancer Res 2007;67:6221-6229.
21. Zhang Y, Lu H, Dazin P, Kapila Y. Squamous cell carcinoma cell aggregates escape suspension-induced, p53-mediated anoikis: fibronectin and integrin alphav mediate survival signals through focal adhesion kinase. J Biol Chem 2004;279:48342-48349.
22. LaBarbera DV, Reid BG, Yoo BH. The multicellular tumor spheroid model for highthroughput cancer drug discovery. Expert Opin Drug Discov 2012;7:819-830.
23. Alpaugh ML, Barsky SH. Reversible model of spheroid formation allows for high efficiency of gene delivery ex vivo and accurate gene assessment in vivo. Human Gene Ther 2002;13:1245-1258.
24. Zhang Z, Han L, Cao L, Liang X, Liu Y, Liu H et al. Aggregation formation mediated anoikis resistance of BEL7402 hepatoma cells. Folia Histochem Cytobiol 2008;46:331-336.
25. Cui Z, Mumper RJ. The effect of co -Administration of adjuvants with a nanoparticle-based genetic vaccine delivery system on the resulting immune responses. Eur J Pharm Biopharm 2003;55:11-18.
26. Cheng L, Ziegelhoffer PR, Yang NS. In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment. Proc Natl Acad Sci USA 1993;90:4455-4459.
27. O'Brien JA, Lummis SC. Biolistic transfection of neurons in organotypic brain slices. Methods Mol Biol 2013;940:157-166.